(Q35958974)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15556807%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

The promise of minocycline in neurology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15556807%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15556807%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

V Wee Yong

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15556807%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Jennifer Wells

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15556807%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Fabrizio Giuliani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15556807%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Steven Casha

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15556807%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Luanne M Metz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15556807%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 December 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15556807%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15556807%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15556807%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15556807%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

744-751

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15556807%20AND%20SRC:MED&resulttype=core&format=json

Minocycline excretion and distribution in relation to renal function in man

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Pharmacokinetic studies on minocycline in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline-induced autoimmune syndromes: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Benefit-risk assessment of acne therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Delayed minocycline but not delayed mild hypothermia protects against embolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Intracerebral hemorrhage induces macrophage activation and matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Metalloproteinases in biology and pathology of the nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Tetracyclines inhibit tissue collagenase activity. A new mechanism in the treatment of periodontal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Inhibition of autoimmune encephalomyelitis by a tetracycline.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Effect of minocycline in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline and doxycycline are not beneficial in a model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline is protective in a mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline delays disease onset and mortality in a transgenic model of ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline enhances MPTP toxicity to dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Inhibitory action of minocycline on lipopolysaccharide-induced release of nitric oxide and prostaglandin E2 in BV2 microglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Suppression of activated microglia promotes survival and function of transplanted oligodendroglial progenitors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Inflammation is detrimental for neurogenesis in adult brain

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLO.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

A novel mechanism of action of tetracyclines: effects on nitric oxide synthases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

The influence of tetracyclines on T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Animal model pharmacokinetics and pharmacodynamics: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Liquid chromatographic determination of minocycline in brain-to-plasma distribution studies in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Clinical pharmacokinetics of doxycycline and minocycline

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Efficient three-drug cocktail for disease induced by mutant superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Gelatinase B/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline for Huntington's disease: an open label study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline in Huntington's disease: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline safety and tolerability in Huntington disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

Minocycline reduces gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2804%2900937-8

7 January 2021

10.1016/S1474-4422(04)00937-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15556807%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference